Dr. Michael A. Schacter is a Yonkers, New York based Periodontics who is specialized in Periodontology. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 944 N Broadway, Suite 107, Yonkers. Patients can reach him at 914-963-7700.
Dr. Michael A. Schacter is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Michael A. Schacter speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Michael A. Schacter
Specialization:
Periodontics
Gender:
Male
Credentials:
D.M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
944 N Broadway, Suite 107, Yonkers, New York, 10701-1304
Phone:
914-963-7700
Fax:
914-963-6592
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
1052624467
Enrollment ID:
I20150714002104
NPI Number:
1932175809
NPI Enumeration Date:
28 Feb, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
944 N Broadway, Suite 107 Yonkers, New York
Zip:
10701-1304
Phone Number:
914-963-7700
Fax Number:
914-963-6592
Patients can reach Dr. Michael A. Schacter at 944 N Broadway, Suite 107, Yonkers, New York or can call to book an appointment on 914-963-7700. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.